Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie

Comprehensibility of Contraindications in German, UK and US Summaries of Product Characteristics/Prescribing Information-A Comparative Qualitative and Quantitative Analysis (2022) Then M, Andrikyan W, Fromm M, Maas R Journal article Renal Transporter-Mediated Drug-Biomarker Interactions of the Endogenous Substrates Creatinine and N-1-Methylnicotinamide: A PBPK Modeling Approach (2022) Tuerk D, Müller F, Fromm M, Selzer D, Dallmann R, Lehr T Journal article Mitochondrial respiration in B lymphocytes is essential for humoral immunity by controlling the flux of the TCA cycle (2022) Urbanczyk S, Baris OR, Hofmann J, Taudte V, Guegen N, Golombek F, Castiglione K, et al. Journal article L-ARGININE REPROGRAMS OSTEOCLAST PURINE METABOLISM AMELIORATING BONE LOSS IN RHEUMATOID ARTHRITIS (2022) Cao S, Song R, Meng X, Kachler K, Fuchs M, Meng X, Li Y, et al. Conference contribution Clarity, clinical applicability and relevance of absolute contraindications in official 'Summaries of Product Characteristics' (SmPCs) (2022) Andrikyan W, Then M, Dürr P, Jung-Poppe L, Schuster A, Weisbach L, Farker K, et al. Conference contribution Improved, but still limited coding of medication-related problems - application of the new WHO ICD-11 code-set to clinical routine data (2022) Jung-Poppe L, Andrikyan W, Altenbuchner A, Pfistermeister B, Dormann H, Fromm M, Maas R Conference contribution Development and validation of an LC-MS method for drug exposure measurement of 57 oral antitumor drugs in human plasma (2022) Kehl N, Dürr P, Schlichtig K, Maas R, Fromm M, Geßner A, Taudte V Conference contribution Inconsistencies and Ambiguities in Liver-Disease-Related Contraindications—A Systematic Analysis of SmPCs/PI of Major Drug Markets (2022) Weisbach L, Schuster AK, Hartmann M, Fromm M, Maas R, Farker K Journal article L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/Nact (2022) Surrer D, Fromm M, Maas R, König J Journal article Identification of diagnosis-related contraindications based on the medication plan alone (2022) Andrikyan W, Then M, Gaßmann KG, Tuemena T, Dürr P, Fromm M, Maas R Conference contribution